GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy is a research paper published in Molecular Therapy β Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 5U01 TR002764-02
National Institutes of Health
Grant: P50 HD105351
NINDS NIH HHS
Grant: U54 NS092090
Intellectual and Developmental Disabilities Research Center
Biogen
National Center for Advancing Translational Sciences
National Institute of Neurological Disorders and Stroke
Astellas Pharma US
Novartis
Keywords